Karen Krasney insider trades
Open-market stock purchases and sales by Karen Krasney, EVP, GENERAL COUNSEL at Capricor Therapeutics, Inc, from SEC Form 4 filings since Jan 21, 2015.
Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +115%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 25, 2026 | CAPR Capricor Therapeutics, Inc | Sold | $732K |
| Jun 25, 2026 | CAPR Capricor Therapeutics, Inc | Bought (not open market) | — |
| Jun 24, 2026 | CAPR Capricor Therapeutics, Inc | Sold | $12K |
| Jun 24, 2026 | CAPR Capricor Therapeutics, Inc | Bought (not open market) | — |
| Jun 22, 2026 | CAPR Capricor Therapeutics, Inc | Sold | $15K |
| Jun 22, 2026 | CAPR Capricor Therapeutics, Inc | Bought (not open market) | — |
| May 1, 2026 | CAPR Capricor Therapeutics, Inc | Sold | $793K |
| May 1, 2026 | CAPR Capricor Therapeutics, Inc | Bought (not open market) | — |
| Mar 31, 2026 | CAPR Capricor Therapeutics, Inc | Sold | $753K |
| Mar 31, 2026 | CAPR Capricor Therapeutics, Inc | Bought (not open market) | — |
| Mar 31, 2026 | CAPR Capricor Therapeutics, Inc | Bought (not open market) | — |
| Mar 31, 2026 | CAPR Capricor Therapeutics, Inc | Bought (not open market) | — |
| Jan 5, 2026 | CAPR Capricor Therapeutics, Inc | Bought (not open market) | — |
| Dec 30, 2025 | CAPR Capricor Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- CAPR Capricor Therapeutics, Inc: 3 buys, 5 sales, last Jun 25, 2026